Known so far: no new shares from the prospectus covers read · shelf room about $9.0M · not yet read: warrants, converts, options, ATM.
Shelf room
Room todayabout $9.0M
One third of float$9.0M ($27.1M float, Jun 30, 2025)
Sold off it, 12 monthsnothing
How this is worked out
Shelf room about $9.0M on the S-3 of Apr 15, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $27.1M public float stated as of Jun 30, 2025, $9.0M, nothing sold off it in the last 12 months. Sources: S-3 Apr 15, 2026, effective May 7, 2026 · public float, as of Jun 30, 2025.
What could become new DataMeds AI (MEDS) shares, from its 10-Q, 10-K, S-1 or 424B filings.
Read so far: the cover share count (3.1M shares, +82% from 1.7M on Aug 19, 2025, adjusted for the 1-for-50 reverse split by Aug 17, 2026). Not read yet: warrants, convertible notes, options and RSUs and an ATM program.Read them on EDGAR: the latest 10-Q · S-1 registration filings.
Registrations and share actions on EDGAR (41 filings)
Registration statements, prospectuses, effectiveness notices, information statements and share sales, newest first. Showing the newest 15 of 41. Each links to the filing on EDGAR.
PRE 14CInformation statement: action approved by written consent (preliminary)
S-1/AAmended registration statement; new shares or resale not read yet
S-1/AAmended registration statement; new shares or resale not read yet
S-1/AAmended registration statement; new shares or resale not read yet
S-1/AAmended registration statement; new shares or resale not read yet
S-1Registration statement; new shares or resale not read yet
Shares outstanding
3.1M
Mar 2025 to Aug 2026: from 1.0M to 3.1M. Adjusted for the 1-for-50 reverse split by Aug 17, 2026: each earlier count is divided by the ratio of every split after it.
From the share count on the cover of each 10-Q and 10-K, dated as each cover states.
Follow DataMeds AI
New shelves, offerings, 10-Qs and 10-Ks from MEDS, explained in plain English when they reach EDGAR.